Yi Ping Li
Fortuna: 3 M $ al 31/12/2025
Perfil
Dr. Yi Ping Li, MD, is a Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd., a Chairman at JW Therapeutics (Shanghai) Co., Ltd. and a Chief Executive Officer & Director at JW Biotechnology (Shanghai) Co. Ltd. He is on the Board of Directors at JW (Cayman) Therapeutics Co. Ltd., JW Biotechnology (Shanghai) Co. Ltd. and GenScript Corp.
Dr. Li was previously employed as a General Manager by Amgen Biotechnology Consulting Shanghai Co., Ltd., a Partner by Kleiner Perkins Caufield & Byers LLC, a Medical Director by Merck Serono SA, and a Partner by KPCB (China) Advisory Co. Ltd. He also served on the board at China Kanghui Holdings.
He received his graduate degree from The University of Montana and a doctorate degree from Shanghai Jiao Tong University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 07/07/2025 | 9.206.460 ( 2,21 % ) | 3 M $ | 31/12/2025 |
Cargos activos de Yi Ping Li
| Empresas | Cargo | Inicio |
|---|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Fundador | 06/09/2017 |
GenScript Corp.
GenScript Corp. BiotechnologyHealth Technology Provides biological research and drug discovery services to pharmaceutical companies | Director/Miembro de la Junta | 27/07/2010 |
JW Biotechnology (Shanghai) Co. Ltd. | Fundador | - |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. Develops cell-based immunotherapies to treat cancer | Fundador | 01/02/2016 |
Antiguos cargos conocidos de Yi Ping Li.
| Empresas | Cargo | Fin |
|---|---|---|
Amgen Biotechnology Consulting Shanghai Co., Ltd. | Director Ejecutivo | 01/07/2015 |
China Kanghui Holdings
China Kanghui Holdings Medical SpecialtiesHealth Technology Researches, develops and distributes orthopedic implants and instruments | Director/Miembro de la Junta | 08/11/2010 |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Researches and manufactures therapeutic products | Corporate Officer/Principal | 30/08/2006 |
Kleiner Perkins Caufield & Byers LLC
Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers invests in companies located in the United States. The firm targets companies operating in consumer, enterprise, Fintech, hardtech and healthcare sectors. It provides financing for seed, early, and later stage capital requirements. | Corporate Officer/Principal | - |
KPCB (China) Advisory Co. Ltd.
KPCB (China) Advisory Co. Ltd. Investment ManagersFinance KPCB China Advisory is an active manager which invests in companies located in China. The firm focuses on companies operating in the fields of digital, green tech and life science opportunities. It participates in seed, early and later-stage capital requirements. | Corporate Officer/Principal | - |
Formación de Yi Ping Li.
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Kleiner Perkins Caufield & Byers LLC
Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers invests in companies located in the United States. The firm targets companies operating in consumer, enterprise, Fintech, hardtech and healthcare sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
The University of Montana
The University of Montana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Jiao Tong University
Shanghai Jiao Tong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Researches and manufactures therapeutic products | Health Technology |
KPCB (China) Advisory Co. Ltd.
KPCB (China) Advisory Co. Ltd. Investment ManagersFinance KPCB China Advisory is an active manager which invests in companies located in China. The firm focuses on companies operating in the fields of digital, green tech and life science opportunities. It participates in seed, early and later-stage capital requirements. | Finance |
GenScript Corp.
GenScript Corp. BiotechnologyHealth Technology Provides biological research and drug discovery services to pharmaceutical companies | Health Technology |
China Kanghui Holdings
China Kanghui Holdings Medical SpecialtiesHealth Technology Researches, develops and distributes orthopedic implants and instruments | Health Technology |
JW Biotechnology (Shanghai) Co. Ltd. | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. Develops cell-based immunotherapies to treat cancer | |
JW (Cayman) Therapeutics Co. Ltd.
JW (Cayman) Therapeutics Co. Ltd. Operates as biotechnology company that develops and manufactures cell immunotherapy products | |
Amgen Biotechnology Consulting Shanghai Co., Ltd. |
- Bolsa de valores
- Insiders
- Yi Ping Li
















